Lateral Flow Thin Layer Chromatography (LF TLC): Instrumentation to Enable In Situ Separation of Organics

The technology provides miniaturized techniques for extracting trace amounts of organic molecules (lipids) from natural samples. It operates as an autonomous, miniaturized fluidic system, integrating lab techniques for lipid analysis while minimizing reagent volumes and concentrating organics for analysis, thereby increasing signal-to-noise ratios by orders of magnitude. The non-aqueous fluidic system described herein for astrobiological and life-detection missions (either in situ or returned sample) is configured to extract lipid organics from regolith using (1) a fluidic sample processor made of materials compatible with organic solvents and (2) a machine-learning system to select processing steps and parameters to maximize lipid yield. A critical gap is bridged by integrating technologies into a system that replicates analytical lab procedures autonomously on a spaceflight instrument scale with fidelity to original lab techniques. Automated fluidic devices combine controlled handling of liquids with sequential operations and parallelization of replicate processes. By designing such systems to closely interface with both sample-delivery and analytical measurement systems, laboratory analyses are automated. The technology adapts best practice laboratory methods for lipid analysis, overcoming analytical challenges like low organic abundance, interference of minerals/salts, and degradation of origin-diagnostic molecular structures. The extraction and concentration techniques from rock/soil samples can be applied to any biomarkers by changing the solvent, temperature, and agitation.

This invention provides a method and system for fabricating a biomarker sensor array by dispensing one or more entities using a precisely positioned, electrically biased nanoprobe immersed in a buffered fluid over a transparent substrate. Fine patterning of the substrate can be achieved by positioning and selectively biasing the probe in a particular region, changing the pH in a sharp, localized volume of fluid less than 100 nm in diameter, resulting in a selective processing of that region. One example of the implementation of this technique is related to Dip-Pen Nanolithography (DPN), where an Atomic Force Microscope probe can be used as a pen to write protein and DNA Aptamer inks on a transparent substrate functionalized with silane-based self-assembled monolayers. But it would be recognized that the invention has a much broader range of applicability. For example, the invention can be applied to formation of patterns using biological materials, chemical materials, metals, polymers, semiconductors, small molecules, organic and inorganic thins films, or any combination of these.

There is a significant need for an inexpensive biological approach to recover specific, targeted metals and other target materials in e-waste or other aqueous solutions that requires minimal input of resources, including energy. This invention is a method of removing or adsorbing a target substance or material, for example, a metal, non-metal toxin, dye, or small molecule drug, from solution, by functionalizing a substrate with a peptide configured to selectively bind to the target substance or material and to bind to the substrate. The substrate is fungal mycelium, and the naturally-occurring or bioengineered peptide is called a target-binding domain, which is chemically bonded to a selected solid substrate. The target chemical species binds to the target-binding domain and is removed from solution. The target can be any chemical species dissolved or suspended in the solution. Capture of the target by the substrate can isolate and allow removal of the target substance from solution, or for utilization in water filtration, or recovery of targeted chemical species from solution, particularly aqueous solution applications. The peptides used include (i) fusion peptides and/or proteins containing metal-binding domain sequence and optionally containing substrate-binding domain sequence; (ii) fusion peptides/proteins containing a metal-binding domain and a chitin-binding domain; and (iii) nucleic acids encoding fusion peptides and/or proteins containing metal-binding domain sequence. The technology enables simple scale up to a level that could be successfully implemented in an environment with limited resources, such as on a space mission or on earth in developing countries with poor access to clean water.

Environmental Control and Life Support Systems (ECLSS) used for extended space missions must recover and process wastewater to provide potable water for crew consumption and oxygen generation. Exploration mission spacecraft will have a smaller crew than the ISS, meaning demands would typically be less than what full-featured commercial TOC analyzers are designed to provide. Current analyzer technology also has limitations and uncertainties for spaceflight integration, such as part traceability, reliability, material properties for flammability or off-gassing, software and interface that are inconsis-tent with spaceflight needs, human factors, and structural reliability. The MiniTOCA provides a compact solution to the performance demands of onboard water quality analysis for crewed exploration missions through a unique core technology process that facilitates the detection of trace organic compounds in a water sample. It utilizes an ultra-violet oxidation method to activate the dissolved oxygen in the water which results in oxidation of the organic chemicals into carbon dioxide. The carbon dioxide is then measured by a Miniature Tunable Laser Spectrometer (MTLS) by sweeping the carbon dioxide out of the water in a gas / liquid separator using nitrogen gas. This novel process allows for small system sample volumes, small overall size/mass, zero consumables, low average power con-sumption (less than 60W), projected long-life (~10 years), and reliable analytical performance – all addressing critical performance gaps within the current TOC analyzer industry. Lab and environmental testing demonstrated that the MiniTOCA’s architecture is both feasible and is excellent in performance. Potential commercial applications for the MiniTOCA include, but are not limited to, ultra-pure water (UPW) systems; remote, mobile, and distributed environmental water quality monitoring; and specialized industrial process control. Technologies comprising the device lend themselves to miniaturization and are forward leaning in exploration applications. The MiniTOCA is scheduled to be flown and imple-mented aboard the ISS in late 2025.

The technology involves a sophisticated system designed to detect conditions through the analysis of exhaled breath, utilizing an array of nanomaterial sensors fabricated upon a standard printed circuit board with interdigitated electrodes. These sensors are configured to interact with a sample gas that contains various Volatile Organic Compounds (VOCs) associated with a variety of biological conditions. Each sensor consists of nanomaterials, such as carbon nanotubes, composite nanotubes, nanoparticle-doped nanotubes, or polymer-coated nanotubes, all disposed on an electrically conductive structure. These sensors are highly sensitive to specific VOCs at a broad spectrum of concentrations, and each sensor generates a unique measurable electrical signal on interaction with VOCs in the breath that reflects the presence and concentration of specific components in the sample gas. The previously nanosensor diagnosis technology has been further developed to identify 64 specific formulations of nanomaterials that exhibit unique and varying sensitivities to VOCs, which enables unique response signatures to be developed for a wide range of VOCs. A single device may be developed using these principles to detect a variety of health conditions and diseases.